These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 35955152)

  • 41. Effect of cyclodextrin charge on complexation of neutral and charged substrates: comparison of (SBE)7M-beta-CD to HP-beta-CD.
    Zia V; Rajewski RA; Stella VJ
    Pharm Res; 2001 May; 18(5):667-73. PubMed ID: 11465424
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparative evaluation of ketoconazole-β-cyclodextrin systems prepared by coprecipitation and kneading.
    Marzouk MA; Kassem AA; Samy AM; Amer RI
    Drug Discov Ther; 2010 Oct; 4(5):380-7. PubMed ID: 22491243
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Influence of formulation technique for hydroxypropyl-beta-cyclodextrin on the stability of aspirin in HFA 134a.
    Williams RO; Liu J
    Eur J Pharm Biopharm; 1999 Mar; 47(2):145-52. PubMed ID: 10234539
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Complexation of Amlodipine Besylate with β-Cyclodextrin.
    Bradea O; Kacso I; Borodi G; Bende A; Bratu I
    Acta Chim Slov; 2012 Mar; 59(1):18-23. PubMed ID: 24061168
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Development of effervescent tablets containing benzonidazole complexed with cyclodextrin.
    Maximiano FP; Costa GH; de Sá Barreto LC; Bahia MT; Cunha-Filho MS
    J Pharm Pharmacol; 2011 Jun; 63(6):786-93. PubMed ID: 21585376
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Study on the inclusion complexes of cryptotanshinone with beta-cyclodextrin and hydroxypropyl-beta-cyclodextrin.
    Li JF; Wei YX; Ding LH; Dong C
    Spectrochim Acta A Mol Biomol Spectrosc; 2003 Oct; 59(12):2759-66. PubMed ID: 14499836
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Influence of hydroxypropyl-beta-cyclodextrin complexation on piroxicam release from buccoadhesive tablets.
    Jug M; Bećirević-Laćan M
    Eur J Pharm Sci; 2004 Feb; 21(2-3):251-60. PubMed ID: 14757497
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Solid state characterization of α-tocopherol in inclusion complexes with cyclodextrins.
    Lange K; Gierlach-Hładon T
    Acta Pol Pharm; 2015; 72(1):21-30. PubMed ID: 25850197
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Inclusion complexes of chlorzoxazone with β- and hydroxypropyl-β-cyclodextrin: Characterization, dissolution, and cytotoxicity.
    Tang P; Li S; Wang L; Yang H; Yan J; Li H
    Carbohydr Polym; 2015 Oct; 131():297-305. PubMed ID: 26256188
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Encapsulation and Stabilization of α-Lipoic Acid in Cyclodextrin Inclusion Complex Electrospun Nanofibers: Antioxidant and Fast-Dissolving α-Lipoic Acid/Cyclodextrin Nanofibrous Webs.
    Celebioglu A; Uyar T
    J Agric Food Chem; 2019 Nov; 67(47):13093-13107. PubMed ID: 31693349
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Improvement of dissolution and bioavailability of nitrendipine by inclusion in hydroxypropyl-beta-cyclodextrin.
    Choi HG; Kim DD; Jun HW; Yoo BK; Yong CS
    Drug Dev Ind Pharm; 2003 Nov; 29(10):1085-94. PubMed ID: 14677769
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Dissolution properties and characterization of halofantrine-2-hydroxypropyl-beta-cyclodextrin binary systems.
    Onyeji CO; Omoruyi SI; Oladimeji FA
    Pharmazie; 2007 Nov; 62(11):858-63. PubMed ID: 18065103
    [TBL] [Abstract][Full Text] [Related]  

  • 53. In vitro and in vivo evaluation of oral tablet formulations prepared with ketoconazole and hydroxypropyl-beta-cyclodextrin.
    Taneri F; Ozcan I; Guneri T
    Drug Deliv; 2010 Apr; 17(3):152-7. PubMed ID: 20148713
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Alternative oral exemestane formulation: improved dissolution and permeation.
    Yavuz B; Bilensoy E; Vural I; Sumnu M
    Int J Pharm; 2010 Oct; 398(1-2):137-45. PubMed ID: 20678561
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Preparation of coated tablets of glycyrrhetic acid-HP-beta-cyclodextrin tablets for colon-specific release].
    Cui QH; Cui JH; Zhang JJ
    Zhongguo Zhong Yao Za Zhi; 2008 Oct; 33(20):2339-43. PubMed ID: 19157122
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Bupivacaine hydrochloride complexation with some alpha- and beta-cyclodextrins studied by potentiometry with membrane electrodes.
    Kopecký F; Vojteková M; Kaclík P; Demko M; Bieliková Z
    J Pharm Pharmacol; 2004 May; 56(5):581-7. PubMed ID: 15142334
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Spray-dried mucoadhesive microparticles based on S-protected thiolated hydroxypropyl-β-cyclodextrin for budesonide nasal delivery.
    Racaniello GF; Laquintana V; Summonte S; Lopedota A; Cutrignelli A; Lopalco A; Franco M; Bernkop-Schnürch A; Denora N
    Int J Pharm; 2021 Jun; 603():120728. PubMed ID: 34029665
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Development of orally disintegrating tablets of Perphenazine/hydroxypropyl-β-cyclodextrin inclusion complex.
    Wang L; Zeng F; Zong L
    Pharm Dev Technol; 2013; 18(5):1101-10. PubMed ID: 22759202
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Development of fast-dissolving tablets of flurbiprofen-cyclodextrin complexes.
    Cirri M; Rangoni C; Maestrelli F; Corti G; Mura P
    Drug Dev Ind Pharm; 2005 Aug; 31(7):697-707. PubMed ID: 16207617
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hot-melt extrusion as a continuous manufacturing process to form ternary cyclodextrin inclusion complexes.
    Thiry J; Krier F; Ratwatte S; Thomassin JM; Jerome C; Evrard B
    Eur J Pharm Sci; 2017 Jan; 96():590-597. PubMed ID: 27687637
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.